1
|
RALLI M, TROIANI D, PODDA M, PACIELLO F, ERAMO S, DE CORSO E, SALVI R, PALUDETTI G, FETONI A. The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats. Acta Otorhinolaryngol Ital 2014; 34:198-204. [PMID: 24882929 PMCID: PMC4035835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/05/2013] [Accepted: 06/27/2013] [Indexed: 11/15/2022]
Abstract
Short-term tinnitus develops shortly after the administration of a high dose of salicylate. Since salicylate selectively potentiates N-methyl- D-aspartate (NMDA) currents in spiral ganglion neurons, it may play a vital role in tinnitus by amplifying NMDA-mediated neurotransmission. The aim of this study was to determine whether systemic treatment with a NMDA channel blocker, memantine, could prevent salicylate-induced tinnitus in animals. Additional experiments were performed to evaluate the effect of memantine on the auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE) to test for changes in hearing function. Thirty-six rats were divided into 3 groups and treated daily for four consecutive days. One group (n = 12) was injected with salicylate (300 mg/kg/d, IP), the second (n = 12) was treated with memantine (5 mg/kg/d, IP) and the third group (n = 12) was injected with salicylate and memantine. All rats were tested for tinnitus and hearing loss at 2, 24, 48 and 72 h after the first drug administration and 24 h post treatment; tinnituslike behaviour was assessed with gap prepulse inhibition of acoustic startle (GPIAS), and hearing function was measured with DPOAE, ABR and noise burst prepulse inhibition of acoustic startle (NBPIAS). Rats in the salicylate group showed impaired GPIAS indicative of transient tinnitus-like behaviour near 16 kHz that recovered 24 h after the last salicylate treatment. Memantine did not cause a significant change in GPIAS. Combined injection of salicylate and memantine significantly attenuated GPIAS tinnitus-like behaviour at 48 hours after the first injection. None of the treatments induced permanent threshold shifts in the ABR and DPOAE, which recovered completely within one day post treatment. Animals treated with salicylate plus memantine showed results comparable to animals treated with salicylate alone, confirming that there is no effect of memantine on DPOAE which reflects OHC function. The present study confirms the role of cochlear NMDA receptors in the induction of salicylate-induced tinnitus.
Collapse
Affiliation(s)
- M. RALLI
- Institute of Otolaryngology, Università Cattolica del Sacro Cuore, Roma, Italy;,Address for correspondence: Massimo Ralli, Institute of Otolaryngology, Università Cattolica del Sacro Cuore, largo A. Gemelli 8, Rome Italy. E-mail:
| | - D. TROIANI
- Institute of Physiology, Università Cattolica del Sacro Cuore, Roma, Italy
| | - M.V. PODDA
- Institute of Physiology, Università Cattolica del Sacro Cuore, Roma, Italy
| | - F. PACIELLO
- Institute of Otolaryngology, Università Cattolica del Sacro Cuore, Roma, Italy
| | - S.L.M. ERAMO
- Institute of Physiology, Università Cattolica del Sacro Cuore, Roma, Italy
| | - E. DE CORSO
- Institute of Otolaryngology, Università Cattolica del Sacro Cuore, Roma, Italy
| | - R. SALVI
- Center for Hearing and Deafness, Department of Communicative Disorders and Sciences, University at Buffalo, NY
| | - G. PALUDETTI
- Institute of Otolaryngology, Università Cattolica del Sacro Cuore, Roma, Italy
| | - A.R. FETONI
- Institute of Otolaryngology, Università Cattolica del Sacro Cuore, Roma, Italy
| |
Collapse
|
2
|
FETONI A, ERAMO S, ROLESI R, TROIANI D, PALUDETTI G. Antioxidant treatment with coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model. Acta Otorhinolaryngol Ital 2012; 32:103-10. [PMID: 22767971 PMCID: PMC3383078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/27/2011] [Accepted: 12/22/2011] [Indexed: 11/18/2022]
Abstract
Aminoglycosides, such as gentamycin, are well known ototoxic agents. Toxicity occurs via an activation process involving the formation of an iron-gentamycin complex with free radical production. Antioxidants like Q-ter (a soluble formulation of coenzyme Q(10), CoQ(10)), can limit or prevent cellular ototoxic damage. The present study was designed to investigate the possible protective effects of Q-ter on gentamycin ototoxicity in albino guinea pigs (250-300 g). Animals were divided into five experimental groups: I, a sham control group given an intra-peritoneal (I.P.) injection of 0.5 ml saline (SHAM); II, gentamycin group (GM), treated with an injection of gentamycin (100 mg/ kg); III, gentamycin + Q-ter group (GM+Q-ter), treated with gentamycin (same dose as group II) and an I.P. injection of coenzyme Q(10) terclatrate (Q-ter) at 100 mg/kg body weight; IV, injected with gentamycin (100 mg/kg) plus saline; V, treated with Q-ter alone (100 mg/ kg). All animals were treated for 14 consecutive days. Auditory function was evaluated by recording auditory brainstem responses (ABR) at 15 and 30 days from the beginning of treatment. Morphological changes were analyzed by rhodamine-phalloidine staining. Gentamycin-induced progressive high-frequency hearing loss of 45-55 dB SPL. Q-ter therapy slowed and attenuated the progression of hearing loss, yielding a threshold shift of 20 dB. The significant loss of outer hair cells (OHCs) in the cochlear medio-basal turn in gentamycin-treated animals was not observed in the cochleae of animals protected with Q-ter. This study supports the hypothesis that Q-ter interferes with gentamycin-induced free radical formation, and suggests that it may be useful in protecting OHC function from aminoglycoside ototoxicity, thus reducing hearing loss.
Collapse
Affiliation(s)
| | - S.L.M. ERAMO
- Human Physiology, Catholic University of Rome, Italy
| | | | - D. TROIANI
- Human Physiology, Catholic University of Rome, Italy,Address for correspondence: Diana Troiani, Institute of Human Physiology, Catholic University of Rome, largo Francesco Vito 1, 00168 Rome, Italy. Tel. +39 06 30154966. E-mail:
| | | |
Collapse
|